Literature DB >> 6979358

Purification of colony-stimulating factor by affinity chromatography.

A Waheed, R K Shadduck.   

Abstract

Studies were undertaken to determine whether L-cell-derived colony-stimulating factor (CSF) could be purified by a single step affinity chromatographic technique. A quantity of 100 X 10(6) units of purified anti-CSF was coupled to cyanogen bromide activated Sepharose 4B; colony assays revealed complete binding of the antibodies to the gel. Three 10-liter pools of serum-free L-cell CSF were concentrated by ultrafiltration, applied to the gel, and eluted with a low pH, high molarity buffer. Recovery of CSF ranged from 68%-100% with greater than 1000-fold decreases in protein content. Specific activity of the purified CSF ranged from 2.8 to 5.9 X 10(7) U of CSF/mg protein. Following iodination, each purified pool of CSF revealed a major 63,000-dalton peak of radioactivity that comigrated with CSF activity in SDS-acrylamide gels. In addition, several smaller peaks of 50,000 and 40,000 molecular weight were also detected. Approximately two-thirds of the purified CSF was adherent to concanavalin-A with elution by a competing sugar. Electrophoretic mobility was retarded by incubation with neuraminidase. These chromatographic studies confirm the observation that CSF is a glycoprotein but also suggest variable degrees of glycosylation of the molecule. This chromatographic technique should prove useful in the rapid purification of large quantities of CSF for physiologic and biochemical characterization.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979358

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Studies of human megakaryocytopoiesis using an anti-megakaryocyte colony-stimulating factor antiserum.

Authors:  H H Yang; E Bruno; R Hoffman
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

2.  The effects of interleukins and other soluble factors on T-lymphocyte colony formation.

Authors:  A Winkelstein; P L Simon; D Wood; L L Machen; R K Shadduck; A Waheed
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

3.  Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice.

Authors:  H E Broxmeyer; D E Williams; S Cooper; R K Shadduck; S Gillis; A Waheed; D L Urdal; D C Bicknell
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

4.  Purification and partial characterization of a megakaryocyte colony-stimulating factor from human plasma.

Authors:  R Hoffman; H H Yang; E Bruno; J E Straneva
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

5.  Amino-terminal amino acid sequence of murine colony-stimulating factor 1.

Authors:  C M Ben-Avram; J E Shively; R K Shadduck; A Waheed; T Rajavashisth; A J Lusis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

6.  Macrophage colony-stimulating factor enhances the expression of Fc receptors on murine peritoneal macrophages.

Authors:  D M Magee; E J Wing; N M Ampel; A Waheed; R K Shadduck
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

7.  Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor 1, recombinant murine interleukin 3, and recombinant murine granulocyte/macrophage colony-stimulating factor.

Authors:  H E Broxmeyer; D E Williams; G Hangoc; S Cooper; S Gillis; R K Shadduck; D C Bicknell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.